Our Science
Our solution, shown as biology in motion.
Kynova is developing a multifunctional peptide therapy approach for atopic dermatitis designed to address the interconnected biology of inflammation, barrier dysfunction, and skin repair through a more targeted therapeutic strategy.
Hover or tap a card to explore how the platform evolves from disease biology to KYN‑001, KYN‑002, and our translation strategy.
Skin cross‑section
Where the biology lives
Active trouble spot · Chronic Th2 inflammation · itch signaling
Module A · acts in dermis
Inflammation
Compact anti‑inflammatory peptide motif
A
About this module
Module A is built around a compact anti‑inflammatory peptide motif designed to modulate key pathways driving chronic inflammation in atopic dermatitis. It reduces production of pro‑inflammatory mediators and dampens upstream signaling cascades that sustain disease activity, while preserving core immune defense.
What it’s there to do
- Attenuate excessive inflammatory signaling in the local tissue environment
- Decrease cytokine and chemokine signals associated with flares
- Create a permissive context for barrier recovery and microbial control rather than broadly suppressing immunity
In programs
KYN-001KYN-002